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Abstract
Background: The incidence of tuberculosis (TB) in the Democratic Republic of the Congo (DRC) is 323/100,000. A
context of civil conflict, internally displaced people and mining activities suggests a higher regional TB incidence in
North Kivu. Médecins Sans Frontières (MSF) supports the General Reference Hospital of Masisi, North Kivu, covering
a population of 520,000, with an elevated rate of pediatric malnutrition. In July 2017, an adapted MSF pediatric TB
diagnostic algorithm, including Xpert MTB/RIF on gastric aspirates (GAs), was implemented. The aim of this study
was to evaluate whether the introduction of this clinical pediatric TB diagnostic algorithm influenced the number
of children started on TB treatment.
Methods: We performed a retrospective analysis of pediatric TB cases started on treatment in the inpatient
therapeutic feeding centre (ITFC) and the pediatric ward. We compared data collected in the second half (July to
December) of 2016 (before introduction of the new diagnostic algorithm) and the second half of 2017. For the
outcome variables the difference between the two years was calculated by a Pearson Chi-square test.
Results: In 2017, 94 GAs were performed, compared to none in 2016. Twelve percent (11/94) of samples were
Xpert MTB/RIF positive. Sixty-eight children (2.9% of total exits) aged between 3 months and 15 years started TB
treatment in 2017, compared to 19 (1.4% of total exits) in 2016 (p 0.002). The largest increase in pediatric TB
diagnoses in 2017 occurred in patients with a negative Xpert MTB/RIF result, but clinically highly suggestive of TB
according to the newly introduced diagnostic algorithm. Fifty-two (3.1%) children under five years old started
treatment in 2017, as compared to 14 (1.3%) in 2016 (p 0.004). The increase was less pronounced and not
statistically significant in older patients: sixteen children (2.6%) above 5 years old started TB treatment in 2017 as
compared to five (1.3%) in 2016 (p 0.17).
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Conclusion: After the introduction of an adapted clinical pediatric TB diagnostic algorithm, including Xpert MTB/RIF
on gastric aspirates, we observed a significant increase in the number of children – especially under 5 years old –
started on TB treatment, mostly on clinical grounds. Increased ‘clinician awareness’ of pediatric TB likely played an
important role.
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Background
The UN Sustainable Development Goals have prioritized
ending the epidemic of tuberculosis (TB) by 2030 [1].
This goal is far from being realized. TB remains the
leading infectious killer globally. In 2018, there were
10.0 million estimated new TB cases, with over 1.4 mil-
lion deaths [1]. Ten to 15% of the TB patients in low-
income countries (LIC) are estimated to be children <
15 years [2]. Less than half (43%) of the estimated 1 mil-
lion children with TB were reported to national TB pro-
grams, indicating massive under-diagnosis and
insufficient access to appropriate care [1, 3].
The estimated incidence of TB in the Democratic Re-
public of the Congo (DRC) is 323/100.000 according to
WHO [4]. The real TB burden in North Kivu – a prov-
ince in Eastern Congo – is unknown, but a context of
civil conflict, displaced people and mining activities sug-
gests a higher regional incidence. The Masisi health zone
– in the North Kivu province – covers a population of
520,000. The estimated number of people with TB in the
Masisi health zone – as reported by the Ministry of
Health (MoH) – has grown in the last couple years: from
310 patients in 2015 (60/100.000), to 594 (114/100.000)
in 2016 and 605 in 2017 (116/100.000), but massive
underreporting is suspected [5]. Twentyfive percent of
the TB patients are children. HIV prevalence in the gen-
eral population of the region is less than 1%.
The top 4 of most frequent pathologies in children
under 5 years old in Masisi are lower respiratory tract in-
fections as the first, followed by severe malaria, sepsis
and non-bloody diarrhea. The burden of malnutrition is
high, as shown by a nutrition survey conducted in 2016
by MoH which reported a prevalence of global acute
malnutrition (GAM) of 4,1% (CI 2,8 – 5,9) and severe
acute malnutrition (SAM) of 1% (CI 0,5% - 2,3%) re-
spectively for children of 0–59months in the Masisi re-
gion [5]; this is most likely an underestimation because
of the highly volatile situation in North Kivu. Undernu-
trition increases the risk of TB and TB can cause or
worsen undernutrition [6]. One study estimated that
26% of overall TB cases in 22 high-burden countries are
attributable to undernutrition [7].
Even if pulmonary TB (PTB) is still the most frequent
presentation of TB in children, the burden of extrapul-
monary TB (EPTB) is certainly higher than in adults [8,
9]. It is hard to get good samples in EPTB, but PTB is
also paucibacillary, resulting in the fact that bacteriologic
confirmation is achievable in less than 50% of all chil-
dren with TB [10]. Therefore – even with the most re-
cent advances in molecular diagnostics – TB in children
remains mostly a clinical diagnosis.
Because of their low sensitivity and specificity in chil-
dren < 5 years old, malnourished and HIV+ children,
and the fact that Masisi is a high prevalence area, tuber-
culin skin test (TST) or interferon gamma release assay
(IGRA) are of limited use in our setting [10, 11]. Chest
X-ray can be a useful tool for diagnosis of pulmonary
TB in children, but is not very sensitive and specific, and
operator-dependent [12]. Obtaining expectorated spu-
tum without induction from children for detection of
acid fast bacilli (AFB) is difficult and its examination is
of low yield [13]. The Xpert MTB/RIF, an automated
nucleic acid amplification test that can simultaneously
identify M. tuberculosis and detect rifampicin resistance,
is (although less sensitive than cultures) very specific,
easier to implement than cultures in LIC and less time-
consuming [14]. The sensitivity and specificity of Xpert
MTB/RIF were found to be quite similar for gastric as-
piration (GA) and induced sputum [15]. Because the im-
plementation of diagnostic GA is easier in LIC, we have
chosen to include Xpert MTB/RIF on GA in our
pediatric diagnostic algorithm.
The aim of this study is to evaluate whether the intro-
duction of the Médecins Sans Frontières (MSF) pediatric
TB diagnostic algorithm – which included targeted
Xpert MTB/RIF on GA samples – influenced the num-
ber of children started on TB treatment.
Methods
Study design and study population
We performed a retrospective analysis of TB diagnosis,
TB treatment and overall mortality in children aged be-
tween 28 days of life and 18 years old admitted to the
general pediatric ward and the inpatient therapeutic
feeding centre (ITFC) in the General Reference Hospital
(GRH) of Masisi.
MSF program description
Since 2007, MSF has supported the Masisi health zone.
The aim is to provide free high-quality medical care to a
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population that has experienced nearly constant con-
flict and violence over the past 25 years. At the start,
support was given only to the surgical service (espe-
cially for war-wounded), to victims of sexual violence
and internally displaced persons (IDPs) through mo-
bile clinics. Step by step, this support was extended
to all services of the Masisi GRH, offering 220 beds
and providing care for more than 17,000 people
(among them approximately 35% children) in 2017, to
the Masisi health center (HC) and to the Nyabiondo
referral health center, with inpatient department
(IPD) capacity, 20 km away from Masisi. The latter
centers refer children to the GRH in case of compli-
cations, including when TB is suspected. Ambulances
connect the supported structures. All services are free
of charge.
Diagnostic methods and operational definitions
We introduced an adapted MSF pediatric TB diagnostic
algorithm – including Xpert MTB/RIF on GA samples –
on July 1st 2017 because we had the impression that cli-
nicians underdiagnosed pediatric TB. Gastric aspirates
were performed in a targeted way, following the MSF
pediatric TB diagnostic algorithm (Fig. 1) for all children
admitted in pediatrics or ITFC with a suspicion of TB.
All children with cough > 2 weeks, poor weight gain on
therapeutic feeding (if malnourished), fever > 1 week or a
suspicion of EPTB, were assessed clinically and investi-
gations (e.g. chest x-ray in case of suspicion of pulmon-
ary TB) were done according to the symptoms (Fig. 1).
Antibiotics (according to the clinical diagnosis) were
given for one week, as well as nutritional support and
other treatment according to the clinical findings. If after
Fig. 1 MSF Pediatric TB Diagnostic Algorithm. Médecins Sans Frontières and Partners In Health. Tuberculosis: Practical guide for clinicians, nurses,
laboratory technicians and medical auxiliaries. 2014 Edition
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one week there was no improvement of the symptoms
or nutritional status, another clinical assessment was
done as well as Xpert MTB/RIF on a GA sample (Fig. 1).
Gastric aspiration (GA) was performed according to the
MSF TB Guideline [16]. After correctly placing the naso-
gastric catheter, first the gastric fluid present in the
stomach was aspirated and placed in the sputum con-
tainer, then the stomach was rinsed with 20 to 30ml of
sterile water / NaCl 0,9%, after which another episode of
suctioning was performed. The additionally suctioned
fluid was added to the first sample [16]. Samples were
immediately sent to the local lab (in GRH), where they
were analyzed with our Xpert MTB/RIF. Xpert results
were given the same day or the day after sample collec-
tion. The child was started on TB treatment if the result
of the Xpert was positive, but also in case of a strong
clinical suspicion of TB (‘obvious TB’) (Fig. 1). In case of
a negative Xpert result and no ‘obvious TB’, but persist-
ing symptoms in an HIV-negative child, another week of
symptomatic treatment and nutritional support (in case
of malnutrition) was given. If the final clinical assess-
ment contained two or more of the following elements,
TB treatment was started anyway: poor weight gain,
peristent cough, persistent fever, fatigue/lethargy, chest
x-ray suggestive of TB (Fig. 1). If the child was HIV-
exposed (if very young) or – positive, or a contact of a
TB patient, no additional week of antibiotics or nutri-
tional support was given. In this case the final clinical as-
sessment to decide whether the child was started on TB
treatment or not, was already done after the first week
of complete treatment (Fig. 1).
Data collection and analysis
We used routinely collected data from the MSF monthly
medical report, the pediatric TB register and the lab
Xpert MTB/RIF register. All patient data were anon-
ymized. We compared the 2nd half of 2016 with the 2nd
half of 2017. Categorical variables are presented as n (%)
and their p-values were calculated by χ2. Only for me-
dian ages a non-parametric Mann-Whitney test was
used. Descriptive statistics were performed in SPSS (ver-
sion 24.0; SPSS Inc., IBM, Chicago, IL USA).
Ethical approval and consent to participate
This study satisfies the criteria for reports using rou-
tinely collected programmatic data set by the Médecins
Sans Frontières Ethics Review Board (ERB). Patient iden-
tifying information was removed prior to analysis. As
this was a study of routinely collected monitoring data,
patient consent was not required.
Results
In the last semester of 2017 the total number of exits
from the pediatric department was 1546 as compared to
869 in the last semester of 2016. The number of exits
from ITFC was 762 as compared to 552 in 2016
(Table 1). The increase in both departments was partly
related to an increase in the number of malaria cases
(968 in 2017 vs. 839 in 2016) and the increase in the
ITFC was partly related to ruptures of therapeutic feed-
ing in non-MSF supported structures. However, the
main increase in both departments was related to a
higher number of displaced people. The top 4 of most
frequent pathologies in pediatrics has been constant.
In 2017, 94 GAs were performed according to the
MSF pediatric TB diagnostic algorithm, including Xpert
MTB/RIF on GA samples (Fig. 1), compared to none in
2016. All GA samples were tested with Xpert MTB/RIF
and 12% (11/94) were Xpert MTB positive. No resist-
ance to rifampicin was detected among the 11 positive
Xpert samples (Table 1). Sixty-eight children (2.9% of all
children discharged from either ‘general pediatrics’ or
ITFC) between 3months and 15 years started TB treat-
ment in the second half of 2017, compared to 19 (1.4%
of all children discharged) in 2016 (p 0.002) (Table 2).
When stratified by age, 52 (3.1%) children under five
years old started treatment in the second half of 2017, as
compared to 14 (1.3%) in the second half of 2016 (p
0.004) (Table 2). The increase was less pronounced and
not statistically significant in older patients: sixteen chil-
dren (2.6%) above 5 years old started TB treatment in the
second half of 2017 as compared to five (1.3%) in the sec-
ond half of 2016 (p 0.17) (Table 2). Fifty-seven patients
with a negative Xpert MTB/RIF result, but clinico-
radiological findings highly suggestive of TB – as defined
in the TB diagnostic algorithm, started treatment based
on clinical criteria in the second half of 2017 (Fig. 1). Five
of the pediatric TB patients (26%) were HIV-positive in
2016 as compared to 2 (3%) in 2017 (Table 2).
The total number of deaths in the pediatric ward was
17 (2% of all exits in this ward) in the last semester of
2016 versus 13 (1%) in 2017 (p 0.02); at ITFC the num-
ber of deaths was 43 (8% of all exits in this ward) versus
46 (6%) (p 0.21), respectively (Table 1). The TB fatality
rate went from 42% of pediatric TB patients (n = 8) in
2016 to 25% (n = 17) in 2017 (p 0.3) (Table 2). In 2017
one child (7% of all deaths in the department) who died
in pediatrics and 16 (35%) of children who died in ITFC
had a diagnosis of TB, as compared to three (18%) (p
0.43) and five (12%) (p 0.01) in 2016 (Table 2).
Discussion
The aim of this study was to evaluate whether the intro-
duction of a clinical pediatric TB diagnostic algorithm,
including Xpert MTB/RIF on GA samples, influenced
the number of children started on TB treatment. We
have demonstrated a significant increase in the number
of children started on medication after the introduction
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of this algorithm. This increase was clearly statistically
significant in children under 5 years old, while local cli-
nicians did before not typically consider TB to be preva-
lent in this age group.
Progress in TB diagnosis in children, who have only
recently been recognized to have a huge burden of TB
disease, has been minimal. Over 96% of children who die
from TB worldwide never access treatment, especially in
LIC and conflict-torn regions [17]. Furthermore less
than 15% of eligible children at high risk of developing
TB receive preventive therapy [1, 18].
As stated in the introduction, pediatric TB diagnoses
are primarily clinically-based [10, 18, 19]. The clinical al-
gorithm developed for LIC by the MSF pediatric work-
ing group, together with the Southern African Medical
Unit (SAMU), can be used as a tool for well-nourished
and malnourished children (Fig. 1). Because of the
known role of TB as comorbidity among children with
acute malnutrition, the MSF pediatric TB diagnostic al-
gorithm emphasizes the need to routinely screen all mal-
nourished children for TB and manage those at risk
appropriately (Fig. 1). Asking about contacts with TB pa-
tients should be included as part of the initial history for
children in nutrition programs, as outlined in the WHO
manual on the management of severe malnutrition,
followed by a diagnostic algorithm, like ours [20, 21]
(Fig. 1).
Gastric aspiration (GA) and Xpert MTB/RIF
Zar et al stated in 2005 that sputum induction is better
than GA in children because three GAs were necessary
to obtain the same diagnostic yield as one induced spu-
tum specimen in her setting in Cape Town and the risk
of nosocomial transmission is lower in children than in
adults [13]. But sputum induction should be done in an
isolation room with adequate ventilation and proper
Table 1 General information and overall mortality in the pediatric ward and ITFC of Masisi GRH. Categorical variables are presented
as n (%) and their p-values were calculated by χ2
Column1 2nd semester 2016 2nd semester 2017 p-value
Total exits 1421 2308 N/A
Overall inpatient pediatric mortality
(% of all children discharged from both wards)
60 (4%) 59 (3%) 0.005
Mortality ITFC
(% of children discharged from ITFC)
43 (8%) 46 (6%) 0.21
Mortality pediatric ward
(% of children discharged from pediatric ward)
17 (2%) 13 (1%) 0.02
Table 2 Specific information related to pediatric TB patients in GRH Masisi. Categorical variables are presented as n (%) and their p-
values were calculated by χ2. Only for median ages a non-parametric Mann-Whitney test was used. N/A = not applicable
Column1 2nd semester 2016 2nd semester 2017 p-value
Total pediatric TB diagnoses
(% of all children discharged)
19 (1.4%) 68 (2.9%) 0.002
TB diagnoses under 5 years
(% of all children under 5 discharged)
14 (1.3%) 52 (3.1%) 0.004
TB diagnoses 5 to 18 years
(% of all children above 5 discharged)
5 (1.3%) 16 (2.6%) 0.17
GA Xpert MTB positive
(% of all pediatric TB diagnoses)
No Xpert done 11 (16%) N/A
Rifampicine resistence detected
(% of all pediatric TB diagnoses)
No Xpert done 0 (0%) N/A
HIV-positive
(% of all pediatric TB diagnoses)
5 (26%) 2 (3%) 0.07
Median Age
(Interquartile Range)
20 m (12m – 62 m) 36m (23,5 m – 60 m) 0.27
Female
(% of all pediatric TB diagnoses)
6 (32%) 36 (53%) 0.10
Pediatric TB fatality rate
(% of all pediatric TB diagnoses)
8 (42%) 17 (25%) 0.30
TB deaths in ITFC
(% of all deaths in ITFC)
5 (12%) 16 (35%) 0.01
TB deaths in pediatric ward
(% of all deaths in pediatric ward)
3 (18%) 1 (7%) 0.43
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personal respiratory protection, which is not always easy
in low-resource settings [22]. Newer studies found that
the bacteriological yield of GA and sputum induction
are more or less similar [15, 23]. For these reasons and
because of its simplicity, GA remains the most common
method for obtaining respiratory samples from children.
Therefore and in order to increase not only the sensitiv-
ity, but especially awareness of clinicians about pediatric
TB, we decided to include Xpert MTB/RIF on GA in
our protocol.
It is important that the procedure of gastric aspiration
is performed correctly to increase the diagnostic yield.
In many settings aspiration is only done once, while it is
advised to rinse the stomach with sterile water/NaCl 0,
9% and to suction again afterwards, especially when not
a lot of sputum was obtained upon the first suctioning
[16, 24]. At the time of the introduction of the Xpert
MTB/RIF in Masisi, the MSF TB Protocol for gastric as-
piration was reinforced by theoretical and bedside teach-
ing, with successful results. Use of the Xpert MTB/RIF
test on GA may be especially beneficial in settings where
mycobacterial culture is not feasible, like LIC and con-
flict zones, esp. for children who cannot produce sputum
spontaneously.
Although age-disaggregated data on MDR-TB are not
even reported to national authorities, indications are that
less than 10% of the estimated 30.000 children who de-
velop MDR-TB every year are diagnosed [18, 25, 26].
The fact that Xpert MTB/RIF already comes with an ini-
tial (and quick) evaluation of rifampicin resistance
(which should be further explored by culture if positive)
is another advantage of the use of Xpert MTB/RIF on
GA samples as a part of our algorithm. Fortunately we
did not find any cases of rifampicin resistance in our
Xpert positive pediatric cases, but the sample size was
very low.
Clinical diagnosis
We observed a significant increase in the number of
children started on TB treatment after implementation
of our clinical algorithm. Most of the children who
started treatment were not positive on Xpert MTB/RIF,
which raises questions about its necessity in our algo-
rithm. However, the high incidence of TB in children is
often seriously underestimated. This was also the case
with our local clinicians in Masisi GRH in DRC. The
doctors were surprised that several pediatric samples
were positive, which brought about a behaviour change
and lowered the threshold to start TB treatment on clin-
ical grounds as well (using our newly introduced clinical
diagnostic algorithm). We believe that increased ‘clin-
ician awareness’ (becoming more aware that children do
frequently have TB) played an important role in the
higher number of diagnoses in 2017.
The overall pediatric TB fatality rate went down from
42 to 25% after the introduction of our algorithm
(Table 2), what could point in the direction of earlier
diagnoses, but this difference was not statistically signifi-
cant. Thirty-five percent of children who died in our
ITFC had a diagnosis of TB in 2017 (almost 3 times
more than in 2016): this might be an overestimation,
since TB treatment can sometimes be a ‘treatment of
last resort’ (especially now that Masisi doctors are more
aware of TB as a frequent pediatric diagnosis) (Table 2).
But a high number of TB deaths in the malnutrition
ward does correspond to the literature, and lowering the
threshold for TB treatment in these very sick malnour-
ished children who mostly have several infections to-
gether however, is justified.
Besides the implementation of our TB diagnostic algo-
rithm, different more general pediatric trainings on di-
verse subjects (pediatric resuscitation, malaria diagnosis
and treatment, shock management and rational use of
antibiotics) were also given in 2017 and the reduced
overall mortality in the general pediatric ward can of
course not be solely attributed to our intervention; al-
though, it could be one of the contributing factors. The
significant increase in the number of children started on
TB treatment, however, is, in our view, mostly due to
the newly introduced adapted clinical pediatric TB diag-
nostic algorithm.
Limitations
This study has several limitations, including the fact that
it is a retrospective analysis of routinely collected data,
in an unstable setting. Therefore, some important pa-
tient and disease information was missing. Our main
data source was the pediatric TB register, where the site
of the disease (PTB or EPTB) or the ward of admission
(pediatric or ITFC) was not systematically recorded. An-
other limitation is the lack of a gold standard to confirm
TB diagnosis among children started on TB treatment
on clinical/radiological basis. We could therefore not as-
sess the accuracy of the diagnostic algorithm and we
cannot confirm that all children who were diagnosed
and started on treatment actually had TB.
Conclusion
Great progress has been made in the ‘End-TB’ strategy
of WHO in recent years. However, pediatric TB still re-
mains underdiagnosed and an important cause of under-
five mortality, especially in malnourished children [27,
28].
Pediatric TB is still a clinical diagnosis. In Masisi we
have shown that improving TB diagnosis in children -
with an adapted clinical TB diagnostic algorithm, includ-
ing Xpert MTB/RIF on GA samples - can be feasible
and effective in a Central-African conflict setting with a
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high malnutrition and TB burden. Increased ‘clinician
awareness’ of pediatric TB likely played an important
role in this.
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